Josie E. Parker

Mutations in <i>TAC1B</i> : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

Jeffrey M. Rybak, José F. Muñoz, Katherine S. Barker et al. · mBio · 2020 · 197 citations · Full text

Life Sciences, Genetics, Microbiology +17

Characterization of the sterol 14α‐demethylases of <i>Fusarium graminearum</i> identifies a novel genus‐specific <scp>CYP</scp>51 function

Jieru Fan, Martin Urban, Josie E. Parker et al. · New Phytologist · 2013 · 175 citations · Full text

Life Sciences, Microbiology, Plant Biology +17

Identification and Characterization of Four Azole-Resistant <i>erg3</i> Mutants of <i>Candida albicans</i>

Claire M. Martel, Josie E. Parker, Oliver Bader et al. · Antimicrobial Agents and Chemotherapy · 2010 · 169 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

Andrew G. S. Warrilow, Claire M. Hull, Josie E. Parker et al. · Antimicrobial Agents and Chemotherapy · 2014 · 166 citations · Full text

Medicine, Microbiology, Pharmacology +17

A Clinical Isolate of <i>Candida albicans</i> with Mutations in <i>ERG11</i> (Encoding Sterol 14α-Demethylase) and <i>ERG5</i> (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B

Claire M. Martel, Josie E. Parker, Oliver Bader et al. · Antimicrobial Agents and Chemotherapy · 2010 · 164 citations · Full text

Life Sciences, Microbiology, Pharmacology +17